The recreational use of cannabis was legalized in Canada on 17 October 2018. It is legal for both recreational and medicinal purposes.
As of January 2019, online sales of cannabis for recreational use were well underway across Canada, via the provincial or territorial governments. Most provinces also had storefront operations selling cannabis, either operated by the government or private enterprise. The number of retailers is likely to remain limited, largely due to insufficient supply of legal cannabis from licensed producers.
Mom Canada (Mail Order Marijuana) are one of the earliest online dispensaries that sell quality medical and recreational cannabis products in Canada. The have been shipping their top quality THC and CBD weed edibles, seeds, treats and other goodies to our Canadian customers for quite some time now.
Mom Canada published their Complete Guide to Buying Marijuana Online in 2021.
The Drug Policy Network South East Europe and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) invite you to participate in the webinar that will provide information on the new European Union drug strategy.
The EU Council approved the EU Drugs Strategy on 18 December 2020 setting out the political framework and priorities for the EU’s drug policy in the period 2021-2025. The strategy aims to ensure a high level of health promotion, social stability and security and contribute to awareness raising. On the basis of this strategy, the Council will prepare an action plan which will set out concrete measures to achieve these priorities.
With this strategy, the EU and its member states reaffirm their commitment to an approach which is based on evidence, comprehensive and balanced between demand and supply reduction of drugs, with the preservation of human rights at its core. At the same time, this strategy uses the lessons learned from the COVID-19 crisis in the drugs area and takes a future-oriented approach, promoting research, innovation and foresight to respond more effectively to increasing challenges and to anticipate them.
The webinar may serve as a source of inspiration to support all those involved process of design, implementation and evaluation of drug strategies. It is especially suitable for regional drug strategy makers, regional civil society groups, European and other interested participants.
The EU Drugs Strategy 2021 – 2025 will be presented by Danilo Ballotta, Coordinator – Institutional relations at the EMCDDA.
We also expect inputs from the civil society activists. The full list of speakers will be published before the webinar.
The Webinar will be held via Zoom on Wednesday 24 March 2021 starting at 13:00 CET. The Webinar will last for 90 minutes.
The Webinar will be delivered in English, with translation into Bosnian-Croatian-Montenegrin-Serbian. We are exploring opportunities for translation into other languages of South East Europe.
As the number of participants is limited, please register by Tuesday 23 March using the following link>>>.
The EU drugs agency (EMCDDA) launched today the European Web Survey on Drugs 2021. Targeted at people, aged 18 and over, who have used drugs, the survey aims to improve understanding of patterns of drug use in Europe and help shape future drug policies and interventions.
The voluntary, anonymous survey – one of the agency’s targeted ‘leading-edge’ monitoring methods – will run this year in 31 countries and 28 languages. As in previous years, it will be promoted nationally by the Reitox focal points and their partners, as well as through targeted social media advertisements.
In 2016, the first European Web Survey on Drugs was launched. It ran in 16 countries and more than 80 000 people participated. In 2021, this survey will run in over 30 EU and neighbouring countries!
New to this year’s round is the participation of the agency’s partners from the Western Balkans and the European Neighbourhood Policy area through the Instrument for Pre-accession Assistance (IPA7) and EU4Monitoring Drugs (EU4MD) projects.
The new questionnaire, which will run for six weeks, is structured in modules on: socio-demographics, drug using patterns, access to treatment, access to drugs (amounts usually bought and prices paid) and how COVID-19 has affected patterns of drug use. Its findings will contribute to the emerging knowledge base on drug-using practices in Europe and on the quantities of drugs used. This will help enhance market size estimates at national and European level and contribute to policy development more widely.
As the space for civil society appears to be shrinking in the Western Balkans, this report looks at organized crime and corruption in the region from a civil society perspective. It aims to give an overview of how civil society organizations in the Western Balkans deal with issues related to organized crime and corruption and highlights their main activities and concerns.
The GI-TOC’s experience of engaging with community actors all over the world has shown that individuals and community groups are able to build their individual and collective capacity to respond to and recover from organized crime. This report shows that courageous and committed CSOs across the Western Balkans are doing the same, but would benefit from further support to help strengthen communities’ resilience.
More about the report is available from this video
GI TOC shall present the report at the webinar scheduled for Friday 19 Mar 2021 at 11 AM (CET). Interpretation to Albanian, Macedonian, and Bosnian-Montenegrin-Serbian will be available during the event.
This webinar will draw together insights from civil society actors from across the Western Balkans working on organized crime and corruption and identify good practices across the region. During the 90 minute discussion we will also explore how these organizations’ resilience can be strengthened and how CSOs themselves can contribute to strengthening resilience in their communities and across the region.
European harm reduction services needed to be innovative and adapt very rapidly in response to the fast-changing landscape of the pandemic and its associated national control measures. Preliminary research on the effects of the COVID-19 pandemic on drug services and PWUD has noted decreases in available harm reduction services.
Frontline harm reduction workers play a crucial role in public health response during COVID-19 and are instrumental in implementing these rapid-scale changes required to keep vital services operational.
Their experiences during the pandemic provide critical data to understanding the effect of the pandemic on the vulnerable population of PWUD and the health services they depend on.
This Correlation European Harm Reduction Network (C-EHRN) report on the impact of COVID-19 on vital harm reduction services seeks to bring these voices of front-line workers at drug consumption rooms (DCR’s), harm reduction outreach teams and PWUD themselves to highlight their experiences during the COVID-19 pandemic.
The report includes sections on:
General Harm Reduction Response to COVID-19
Drug Consumption Rooms
Opioid Substitution Treatment (OST)
Government & municipality response
Digital and other Innovations
User experiences in the streets
Social Isolation for PWUD
Our member organisations from Bosnia Herzegovina and Greece contributed to the report with their experience.
The Vienna NGO Committee on Drugs is co-sponsoring several side events at this years CND (12-16 April 2021) and has been asked to nominate speakers. All events will be held online.
The side events where civil society input is expected are:
Family a key social institution for addressing substance use, violence, mental health and promote sustainable development: Lessons learned from parenting under stress, in humanitarian settings and in the context of COVID19
VNGOC Ad Hoc Working Group, NGOs from Asia unite to create a consensus and a call for attention to the challenges in Asia regarding drug matters
No one left behind: UNODC-WHO Programme on Drug Dependence Treatment and Care
Insights into Treatment and Care for People with Drug Use Disorders in Contact with the Criminal Justice System: Alternatives to Conviction or Punishment
Civil Society & COVID-19 – responses during the pandemic
The length of the intervention will depend on the main organiser of the event but will likely be no longer than 5min.
Deadline for applications is 25 March, 11:45 p.m. CET.
The Vienna NGO Committee on Drugs (VNGOC) – the global network of nearly 300 NGOs with the purpose of coordinating and supporting meaningful participation at the CND and other fora – published an urgent position statement. Ahead of the 64th CND in April, with its new hybrid format, the statement outlines our recommendations and expectations for the effective, meaningful participation of civil society online.
The Drug Policy Network South East Europe held the promotion of the Analysis of the data on drug-induced deaths in Serbia 2008 – 2019 on 10 March 2021 with the support of the Office for Combating Drugs of the Government of the Republic of Serbia.
The Western Balkans (Albania, Bosnia and Herzegovina, Kosovo*, Montenegro, North Macedonia and Serbia) registered the main waves of COVID-19 infections later than most of the EU countries, but containment strategies were implemented at the same time and with equal force as in the rest of Europe.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) published Trendspotter briefing: Impact of COVID-19 on drug use and drug services in Western Balkans. This report provides the main results of studies conducted using the trendspotter methodology to explore the impact of the pandemic and associated measures on drug services and people who use drugs in the Western Balkan region.
DPNSEE and our member organisations contributed to the report with information and case studies from the ground.
The main findings are listed below.
Use of alcohol, benzodiazepines, and cocaine was reported to have increased in some subpopulations of people who use drugs. Use of benzodiazepines in combination with opioids was among the common risk behaviours observed during the first weeks of lockdown.
A number of harms were observed among marginalised and injecting drug users, who in some cases lacked resources to satisfy basic needs. Mental health problems were reported among both recreational and problem drug users.
The provision of drug treatment was reduced during the first weeks of the pandemic, affecting mainly new admissions and services provided face to face.
The number of people entering treatment declined between March and May 2020 in almost all countries in the Western Balkan region.
Opioid substitution treatment (OST) centres and harm reduction services mainly remained operational, although under a restricted regime.
The main adaptations to the new situation included use of telemedicine and a relaxation of OST distribution schemes.
Personal protection measures became standard in all treatment and harm reduction facilities, and protective equipment was distributed to clients whenever possible.
The crisis highlighted the fragile position of some service providers and the reliance of harm reduction services on the support of international donors.